Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia D S Ferretti

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|October 14, 2022
Anticancer Therapeutic Strategies Targeting p53 AggregationGiulia D S Ferretti, Julia Quarti, Gileno Dos Santos, et al.
The Journal of Biological Chemistry|August 10, 2013
Intramolecular dynamics within the N-Cap-SH3-SH2 regulatory unit of the c-Abl tyrosine kinase reveal targeting to the cellular membraneGuilherme A P de Oliveira, Elen G Pereira, Giulia D S Ferretti, et al.
Journal of Cellular Physiology|February 13, 2025
Molecular Mechanisms and Therapeutic Implications of Long Non-coding RNAs in Cutaneous Biology and DiseaseAlessandro Zuccotti, Farah Al-Fatyan, Giulia D S Ferretti, et al.
The Journal of Biological Chemistry|January 4, 2019
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cellsLuciana P Rangel, Giulia D S Ferretti, Caroline L Costa, et al.
Chemical Reviews|June 28, 2023
Targeting Biomolecular Condensation and Protein Aggregation against CancerJerson L Silva, Debora Foguel, Vitor F Ferreira, et al.
Iscience|January 26, 2020
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid OligomersMurilo M Pedrote, Michelle F Motta, Giulia D S Ferretti, et al.
Frontiers in Molecular Biosciences|April 27, 2023
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinomaMariana M Paz, Giulia D S Ferretti, Mafalda M C Martins-Dinis, et al.
Biomolecules|April 25, 2020
Recent Synthetic Approaches towards Small Molecule Reactivators of p53Jerson L Silva, Carolina G S Lima, Luciana P Rangel, et al.
Plos One|October 3, 2012
Moniliophthora perniciosa necrosis- and ethylene-inducing protein 2 (MpNep2) as a metastable dimer in solution: structural and functional implicationsGuilherme A P de Oliveira, Elen G Pereira, Cristiano V Dias, et al.
Journal of Neurochemistry|April 3, 2025
Phase Separation and Prion-Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer TreatmentJerson L Silva, Guilherme C de Andrade, Elaine C Petronilho, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|October 14, 2022
Anticancer Therapeutic Strategies Targeting p53 AggregationGiulia D S Ferretti, Julia Quarti, Gileno Dos Santos, et al.
The Journal of Biological Chemistry|August 10, 2013
Intramolecular dynamics within the N-Cap-SH3-SH2 regulatory unit of the c-Abl tyrosine kinase reveal targeting to the cellular membraneGuilherme A P de Oliveira, Elen G Pereira, Giulia D S Ferretti, et al.
Journal of Cellular Physiology|February 13, 2025
Molecular Mechanisms and Therapeutic Implications of Long Non-coding RNAs in Cutaneous Biology and DiseaseAlessandro Zuccotti, Farah Al-Fatyan, Giulia D S Ferretti, et al.
The Journal of Biological Chemistry|January 4, 2019
p53 reactivation with induction of massive apoptosis-1 (PRIMA-1) inhibits amyloid aggregation of mutant p53 in cancer cellsLuciana P Rangel, Giulia D S Ferretti, Caroline L Costa, et al.
Chemical Reviews|June 28, 2023
Targeting Biomolecular Condensation and Protein Aggregation against CancerJerson L Silva, Debora Foguel, Vitor F Ferreira, et al.
Iscience|January 26, 2020
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid OligomersMurilo M Pedrote, Michelle F Motta, Giulia D S Ferretti, et al.
Frontiers in Molecular Biosciences|April 27, 2023
PRIMA-1 inhibits Y220C p53 amyloid aggregation and synergizes with cisplatin in hepatocellular carcinomaMariana M Paz, Giulia D S Ferretti, Mafalda M C Martins-Dinis, et al.
Biomolecules|April 25, 2020
Recent Synthetic Approaches towards Small Molecule Reactivators of p53Jerson L Silva, Carolina G S Lima, Luciana P Rangel, et al.
Plos One|October 3, 2012
Moniliophthora perniciosa necrosis- and ethylene-inducing protein 2 (MpNep2) as a metastable dimer in solution: structural and functional implicationsGuilherme A P de Oliveira, Elen G Pereira, Cristiano V Dias, et al.
Journal of Neurochemistry|April 3, 2025
Phase Separation and Prion-Like Aggregation of p53 Family Tumor Suppressors: From Protein Evolution to Cancer TreatmentJerson L Silva, Guilherme C de Andrade, Elaine C Petronilho, et al.
Pageof 2